Scalable Success

Numbers may hold the clue for a successful weight loss program at your company.

Discover how big numbers and a broad population helped to drive clinically significant results for employee weight loss programs using an intent-to-treat analysis.

Real Results

Making a real difference in the lives of our members.

Study: Help reduce cholesterol and lower the risk of heart disease with Real Appeal

Being overweight or obese may increase your cholesterol and the associated risk for heart disease. Real Appeal found its members better reduced their cholesterol levels in comparison to non-participants. Read More

ROI Study: Real Appeal Is on Track to Meet or Exceed 2:1 ROI over Three Years

Real Appeal’s unique ability to drive participation and produce clinically significant weight loss can translate into meaningful cost savings. An analysis of claims from nearly 22,000 participants demonstrated a 1.5:1 ROI in just 24 months. Read More

White Paper: Every Pound Lost Can Make a Difference for Your Health

Most people assume they have to lose a significant amount of weight to see health benefits; however, research shows losing as little as 3% or 5% body weight can improve a person’s health. Real Appeal’s data reveals the more program sessions a member attended, the more likely he or she was to achieve 5% weight loss — which can help lower blood pressure, reduce the risk of developing type 2 diabetes and reduce health care costs. Read More

White Paper: Making the Science of Behavior Change Appealing

The healthcare industry is facing significant cost increases driven by obesity-related chronic conditions. Traditional weight loss and disease prevention programs have limited success because they don’t address the major obstacles to long term behavior change. Real Appeal’s research reveals strategies and tools that are effective in driving engagement and program persistence. Read More

Study: Real medical cost reduction 

A recent large-scale claims analysis found that Real Appeal delivered a 1:1 ROI in year one, shaving medical costs by as much as 16 percent. Read More

More science behind our success

Want to dig in to what really makes us different? We’ve pulled together peer-reviewed research articles from academic publications that show why we’re able to guarantee our results.

Consensus on Safe and Effective Lifestyle Strategies for Weight Loss

Learn More

Intensive Lifestyle Interventions for Overweight and Obesity Scientific Basis and History

Learn More

Is 5 Percent Weight Loss Satisfactory Criterion for Clinically Significant Weight Loss

Learn More

Long Term Weight Loss with Behavior Change is Possible

Learn More

Modest Weight Loss Can Prevent Type 2 Diabetes

Learn More

Caloric Restriction is Safe and Effective for Weight Loss and Health Benefits

Learn More

You Can Lose Weight Using a Variety of Diet Plans

Learn More

U.S. Preventive Services Task Force Guidelines on Preventive Care

Learn More

Fifty Years of Behavioral/Lifestyle Interventions for Overweight and Obesity: Where Have We Been and Where Are We Going?

Learn More

Clinical Advisors
& Research

Led by experts with real passion.

Our Clinical Advisory Board carefully oversees and guides the addition of each new tool and idea, ensuring consistent support and healthier transformations for each member.

  • Caroline Apovian, M.D., FACP, FACN

  • Louis J. Aronne, M.D., FACP

  • John Foreyt, Ph.D.

  • Donna Ryan, M.D.

  • Steven R. Smith, M.D.

  • Deneen Vojta, M.D.

  • Donald A. Williamson, Ph.D.

  • Rena R. Wing, Ph.D.

*In the past 20 years, researchers have demonstrated that structured weight-loss and lifestyle-change programs can accomplish three critical employee and population health goals:1. Improving overall health outcomes for individuals who are overweight and obese but do not yet have prediabetes or diabetes (Jensen, M.D., Ryan, D.H., Donato, K.A. et al, 2014) 2. Reducing the progression to diabetes in those who have prediabetes (Williamson, D.A., Bray, G.A., & Ryan, D.H, 2015) 3. Improving clinical markers for individuals who already have Type 2 diabetes (Espeland, M.A., Glick, H.A., Bertoni, A., et al for the Look AHEAD Research Group, 2014)